Kovack Advisors, Inc. Trevena Inc Transaction History

Kovack Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$0.62 - $1.06 $6,386 - $10,918	-10,300 Closed	0 $0
Q3 2019 Oct 31, 2019	SELL	$0.81 - $1.06 $2,430 - $3,180	-3,000 Reduced 22.56%	10,300 $10,000
Q2 2019 Aug 14, 2019	SELL	$0.94 - $1.6 $1,880 - $3,200	-2,000 Reduced 13.07%	13,300 $14,000
Q1 2019 May 03, 2019	SELL	$0.51 - $1.88 $1,173 - $4,324	-2,300 Reduced 13.07%	15,300 $24,000
Q4 2018 Feb 06, 2019	BUY	$0.39 - $3.47 $1,170 - $10,410	3,000 Added 20.55%	17,600 $8,000
Q3 2018 Oct 09, 2018	SELL	$1.39 - $2.25 $11,120 - $18,000	-8,000 Reduced 35.4%	14,600 $31,000
Q2 2018 Aug 01, 2018	BUY	$1.44 - $2.24 $1,872 - $2,912	1,300 Added 6.1%	22,600 $33,000
Q1 2018 May 15, 2018	BUY	$1.51 - $2.06 $14,949 - $20,394	9,900 Added 86.84%	21,300 $35,000
Q4 2017 Feb 01, 2018	BUY	$1.4 - $2.6 $1,400 - $2,600	1,000 Added 9.62%	11,400 $18,000
Q3 2017 Aug 02, 2018	BUY	$2.22 - $2.79 $23,088 - $29,016	10,400	10,400 $27,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.